Talk:Treatment Action Group
 | This article is rated C-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||
| |||||||||||
Longevity drugs
There are published studies of longevity improving drugs. Deprenyl, metformin, resveratrol, rapamycin There are also a number of popular articles on longevity science at Scientific American.
What is the right way to suggest to the Treatment Action Group that all hiv persons should be prescribed a longevizing drug as a standard part of their treatment. The "psychology" of this is that if hiv changes lifespan a longevity drug restores full lifespan as a kind of treatment right.
Some longevity drugs that have been published as effective at two or more mammal species. The medical rationale to prescribe experimental drugs that are unapproved is they they may save a persons life. The many years of life saved per person on a longevity drug then may have similar "quantity of life years gained" that goes with a person being cured of cancer, justifying the prescription of only partially researched preFDA longevity compounds to hiv patients.
further, the voluntary use of longevity drugs among hiv persons screens these drugs to benefit everybody.
from a wikipedia perspective the Treatment Action Group should have an online link to treatmentactiongroup.org — Preceding unsigned comment added by 128.223.120.163 (talk) 23 June 2011